DPIIT recognised startup Government of India
Startup India
Hanugen Therapeutics Private Limited - life sciences in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.23 Cr
▲ 23% YoY
Net profit · FY 2025
₹4.94 Lakh
Net margin 4%
EBITDA · FY 2025
₹82.68 Lakh
EBITDA margin 67.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Hanugen Therapeutics Private Limited
Data last updated:
Hanugen Therapeutics Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 20 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2017PTC100686. Its GSTIN is 29AAECH0868G1ZF (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Arun Shastry and Manjulam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.23 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹4.94 Lakh (net margin 4%) and EBITDA of ₹82.68 Lakh (EBITDA margin 67.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 34% over five years.
The company is associated with 1 brand: Hanugen Therapeutics.
Hanugen Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0204492). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hanugen.com.
Company details
CIN U73200KA2017PTC100686
Registration Number 100686
Incorporation Date 20 February 2017
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-KR-03-0204492
Recognitions & Rankings of Hanugen Therapeutics
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0204492
Contact details
Hanugen Therapeutics Private Limited's registered office is in Bangalore, Karnataka. Its website is hanugen.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressNo. 7 Balaji Arcade 3rd Floor Chikkamaranahalli, Opp Hp Petrol Bunk New Bel Road, Bangalore, Karnataka, India – 560094
- IndustryLife Sciences, Biotechnology
To see the full contact details of Hanugen Therapeutics Private Limited, buy the company report.
Comprehensive company report
Hanugen Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hanugen Therapeutics operates one associated brand: Hanugen Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oligonucleotide therapeutics are developed for rare genetic disorders treatment. | hanugen.com |
Business activity
The main business activity of Hanugen Therapeutics is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Hanugen Therapeutics Private Limited, buy the company report.
Financials of Hanugen Therapeutics Private Limited
FY 2025 filings availableHanugen Therapeutics Private Limited reported revenue of ₹1.23 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹1.23 Cr ▲ 23%
Net profit · FY 2025
₹4.94 Lakh margin 4%
EBITDA · FY 2025
₹82.68 Lakh margin 67.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▼ 6%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 110%
3 years · compounded
▲ 88%
5 years · compounded
▲ 85%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 23% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹82.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 67.3% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hanugen Therapeutics Private Limited, buy the company report.
Board of directors of Hanugen Therapeutics Private Limited
Hanugen Therapeutics has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Shastry Also directs: Zigibae Ventures LLP | Director | 20 Feb 2017 | 9 Years 8 Months | Current |
| Manjulam | Director | 20 Feb 2017 | 9 Years 8 Months | Current |
| Rav Deep Singh Anand Also directs: KRM Ananda Ventures Private Limited | Director | 20 Feb 2017 | 9 Years 8 Months | Current |
Auditor
Hanugen Therapeutics Private Limited is audited by SAI GANESH KARTHIK & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAI GANESH KARTHIK & ASSOCIATES | FY 2021 | 013023S |
Shareholding
The shareholding of Hanugen Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hanugen Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hanugen Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hanugen Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hanugen Therapeutics has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECH0868G1ZF | Karnataka | Active | 06 Sep 2017 |
To see the full GST registrations and return filing status of Hanugen Therapeutics Private Limited, buy the company report.
Recent activity
Hanugen Therapeutics Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Arun Shastry was appointed as Director on 20 Feb 2017.
AGM
Hanugen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hanugen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Arun Shastry was appointed as Director.
Appointed
Manjulam was appointed as Director.
Appointed
Rav Deep Singh Anand was appointed as Director.
Incorporation
20 Feb 2017
Hanugen Therapeutics Private Limited was registered on 20 Feb 2017 with Roc Bangalore & aged 9 years 8 months as per MCA records.
Frequently asked questions
Hanugen Therapeutics is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 20 February 2017 (9+ years old) and is registered under CIN U73200KA2017PTC100686.
Hanugen Therapeutics has 3 current directors:
- Arun Shastry - Director
- Manjulam - Director
- Rav Deep Singh Anand - Director
The latest financial statements of Hanugen Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Hanugen Therapeutics is 29AAECH0868G1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Hanugen Therapeutics is U73200KA2017PTC100686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hanugen Therapeutics was incorporated on 20 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
Arun Shastry was appointed as Director on 20 Feb 2017. Manjulam was appointed as Director on 20 Feb 2017. Rav Deep Singh Anand was appointed as Director on 20 Feb 2017.
Yes, Hanugen Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Hanugen Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0204492).
Hanugen Therapeutics can be reached through the website hanugen.com. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages